View Post

Brazil's Dengue Vaccine Production to Reach 100 Million

In COVID-19, Latest News by Precision Vaccinations

The government of São Paulo, Brazil, through the State Department of Health, recently declared a state of public health emergency 'in view of dengue becoming epidemic.'
This agency says the 'cause of concern is the reappearance of the mosquito-transmitted dengue serotype 3 after seventeen years without circulation, as the Sao Pailo State population is not immune to this specific dengue strain.'

View Post

BCG Vaccine Shortage Ends in the United States

In COVID-19, Latest News by Precision Vaccinations

Following years of inadequate supply, a recently approved recombinant Bacillus Calmette-Guérin (rBCG) is now available in the United States to treat non-muscle invasive bladder cancer (NMIBC) patients.
Access to this vaccine may end the multi-year shortage of the TICE® BCG vaccine.

View Post

Zika Returns to Eight Countries in 2025

In COVID-19, Latest News by Precision Vaccinations

Following a record-setting number of Zika virus outbreaks in 2024, the Pan American Health Organization (PAHO) today reported eight counties have confirmed cases in 2025.
On February 18, 2025, the PAHO's data dashboard revealed that 333 Zika cases had already been confirmed in 2025.
Once again, the Federative Republic of Brazil, which has led this unfortunate list in the Region of the Americas for years, has 271 cases, followed by Bolivia, Columbia, Costa Rica, El Salvador, Guatemala, Mexico, and Peru.

View Post

Guillain-Barré Syndrome Risk Identified in Norovirus Vaccine Candidate

In COVID-19, Latest News by Precision Vaccinations

With cruise ship voyages reporting additional norovirus outbreaks in 2025, vaccines that protect people against human norovirus disease are in demand.
Historically, developing a broadly effective norovirus vaccine has been challenging owing to the genetic and antigenic diversity of noroviruses.
Another concern has arisen due to Moderna Inc.'s recent announcement.